John A. Moyer - Concepedia

Author

John A. Moyer

Also Known As

J MOYER, J. A. MOYER, J. A. Moyer, J. Moyer, J.A Moyer, J.A. Moyer, JOHN A. MOYER, Jeffrey Moyer, John A Moyer, John A. Moyer

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Princeton University Janssen (United States)Women's Health Research Institute Experimental Pathology Laboratories CNS Research (United States)

About

John A. Moyer is an author at Princeton University specializing in medicine, pharmacology, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	26	1.7K
2	Social Sciences	7	7	629
3	Natural Sciences	6	6	571
4	Health Sciences	4	4	227
5	Allergy	2	2	42

John A. Moyer

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative Eric A. Muth, J. Thomas Haskins, John A. Moyer, Biochemical Pharmacology Medicinal ChemistryPsychoactive DrugPharmacological StudyBiochemistryPsychiatry	1986	374
Biochemical, neurophysiological, and behavioral effects of Wy‐45,233 and other identified metabolites of the antidepressant venlafaxine Eric A. Muth, John A. Moyer, J. Thomas Haskins, Drug Development Research Psychotropic MedicationPsychopharmacologyOther Identified MetabolitesPharmacotherapyExperimental Pharmacology	1991	210
2-Phenyl-2-(1-hydroxycycloalkyl)ethylamine derivatives: synthesis and antidepressant activity John P. Yardley, G. E. M. Husbands, Gary Stack, Journal of Medicinal Chemistry Rat Pineal GlandPsychopharmacologyOrganic ChemistryPharmacotherapyEthylamine Derivatives	1990	129
Auditory brainstem responses after ovariectomy and estrogen replacement in rat James R. Coleman, William A. Cooper, Marcia G. Welsh, Hearing Research Auditory Brainstem ResponsesNeurophysiologyPhysiologyAuditory CortexNeuroendocrine Mechanism	1994	109
Effects of serotonergic agents on isolation-induced aggression Sheryl M. White, Robert F. Kucharik, John A. Moyer Pharmacology Biochemistry and Behavior Serotonergic AgentsBehavioral SciencesBehavioral NeuroscienceBehavioural PharmacologyBehavioral Pharmacology	1991	108
Synthesis and SAR of Adatanserin: Novel Adamantyl Aryl- and Heteroarylpiperazines with Dual Serotonin 5-HT<sub>1A</sub> and 5-HT<sub>2</sub> Activity as Potential Anxiolytic and Antidepressant Agents Magid Abou‐Gharbia, Wayne E. Childers, Horace Fletcher, Journal of Medicinal Chemistry	1999	82
Stress during pregnancy: effect on catecholamines in discrete brain regions of offspring as adults John A. Moyer, Lorraine Roth Herrenkohl, David M. Jacobowitz Brain Research Early Life StressStress HormonePsychiatryNeurophysiologyNeuroanatomy	1978	79
5HT Antagonists Attenuate MK801-Impaired Radial Arm Maze Performance in Rats Carl A. Boast, Adam C. Bartolomeo, Herman Morris, Neurobiology of Learning and Memory NeurophysiologyMedicinePhysiologyNeurotransmitterNeuropharmacology	1999	73
Design and Synthesis of [2-(8,9-Dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)- ethyl]phosphonic Acid (EAA-090), a Potent <i>N</i>-Methyl-<scp>d</scp>-aspartate Antagonist, via the Use of 3-Cyclobutene-1,2-dione as an Achiral α-Amino Acid Bioisostere William A. Kinney, Magid Abou‐Gharbia, Deanna T. Garrison, Journal of Medicinal Chemistry Bioorganic ChemistryPotent Nmda AntagonistOrganic ChemistryPharmacotherapyHeterocycle Chemistry	1998	71
DMI, Wy-45,030, Wy-45,881 and ciramadol inhibit locus coeruleus neuronal activity J. Thomas Haskins, John A. Moyer, Eric A. Muth, European Journal of Pharmacology MedicineNeuropharmacologyNeuroscienceMolecular NeurobiologyCentral Nervous System	1985	65

Page 1